Program Type: Infrastructure
CIRM Patent Prosecution Assistance Fund for Stem Cell Technologies – UCD
The technology transfer office (TTO) has the primary responsibility of managing intellectual property for the institution. The TTO is well positioned for its mission through an effective functional internal structure to process invention disclosures, evaluate patentability and marketability, to patent inventions, seek out the right licensees and manage post licensing activities. In addition, the TTO […]
Intellectual Property in Regenerative Bioengineering from CIRM funded research in regenerative medicine at the University of California, Santa Barbara.
UCSB’s Office of Technology & Industry Alliances (TIA) was established in 2005 with two primary responsibilities: manage intellectual property from UCSB research (including out-licensing) and manage the many agreements with industry partners who support research collaborations (e.g. research, material transfer, and non-disclosure agreements and memorandums of understanding). Our goal is to build effective, long-term and […]
Patent Assistance Fund – UCLA
As part of the core mission for the campus that bears benefits for faculty, the academic enterprise, and society at-large, our office provides a central role of managing the campus intellectual property and by promoting entrepreneurship and industry engagement. Over the past 20 years, our campus faculty IP has generated more than $280 million license […]
CIRM Patent Assistance Fund Application – UCI
The Office of Technology Alliances (OTA) at UC Irvine is comprised of 12 full-time staff including seven licensing officers and 4 support staff with an average of 10 years of experience in technology licensing (industry & academic). We have access to hundreds of UC approved patent law firms to accomplish the filing, prosecution, and issuance […]
Funding for Patent Applications for CIRM-funded Inventions out of Stanford University
Stanford receives around 500 new invention disclosures per year from a faculty base of over 1,800 members and over 15,000 students, as well as some staff. Our licensing professionals have a wealth of experience in technology transfer as well as business development and evaluate each invention disclosure provided to the office. Most of our licensing […]
Patent Assistance Fund Application – UCSD
The technology transfer office is responsible for protecting, managing and licensing intellectual property (IP), including inventions and research materials in life and physical sciences. These assets are supported by the coordinated efforts of a knowledgeable staff with substantial career experience on a variety of technical fronts (from biology to bioengineering and from physics to devices) […]
The CIRM Human Pluripotent Stem Cell Biorepository – A Resource for Safe Storage and Distribution of High Quality iPSCs
Critical to the long term success of the CIRM iPSC Initiative of generating and ensuring the availability of high quality disease-specific human IPSC lines is the establishment and successful operation of a biorepository with proven methods for quality control, safe storage and capabilities for worldwide distribution of high quality, highly-characterized iPSCs. Specifically the biorepository will […]
Generation and characterization of high-quality, footprint-free human induced pluripotent stem cell lines from 3,000 donors to investigate multigenic diseases
Induced pluripotent stem cells (iPSCs) have the potential to differentiate to nearly any cells of the body, thereby providing a new paradigm for studying normal and aberrant biological networks in nearly all stages of development. Donor-specific iPSCs and differentiated cells made from them can be used for basic and applied research, for developing better disease […]
CIRM Tissue Collection for Neurodevelopmental Disabilities
Most children who go to the clinic with brain disorders have symptoms combining autism, cerebral palsy and epilepsy, suggesting underlying and shared mechanisms of brain dysfunction in these conditions. Such disorders affect 4-6% of the population with life-long disease, and account for about 10% of health care expenditures in the US. Genetic studies have pointed […]
Generation of fibroblast cell lines in patients with common blinding eye diseases
Age-related macular degeneration (AMD), primary open-angle glaucoma (POAG), and proliferative diabetic retinopathy (PDR) are the major causes of irreversible vision loss worldwide. Although the exact causes and mechanisms of these diseases are not completely understood, it is known that genetic and environmental factors contribute to the development of these diseases. Recent scientific advances have enabled […]